verapamil has been researched along with oxalates in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halabe, A; Sutton, RA; Wong, NL | 1 |
| Iguchi, M; Ikegami, M; Ishikawa, Y; Kiwamoto, H; Kohri, K; Kurita, T; Umekawa, T | 1 |
| Chatterjee, A; Choudhuri, SK | 1 |
| Choudhuri, SK | 1 |
| Choudhuri, SK; Majumder, S | 1 |
| Bakir, K; Erbagci, A; Erturhan, S; Sarica, K; Uçak, R; Yağci, F | 1 |
| Bhattacharya, S; Choudhuri, SK; Datta, ER; Dutta, P; Efferth, T; Majumder, S; Mukherjee, P | 1 |
| Altay, B; Erturhan, S; Sarica, K | 1 |
8 other study(ies) available for verapamil and oxalates
| Article | Year |
|---|---|
The effect of verapamil and thiazide in the prevention of renal stone formation.
Topics: Animals; Calcium; Chlorothiazide; Ethylene Glycol; Ethylene Glycols; Hydroxycholecalciferols; Kidney Calculi; Male; Oxalates; Oxalic Acid; Rats; Rats, Inbred Strains; Verapamil | 1990 |
[Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
Topics: Calcium; Citrates; Citric Acid; Female; Humans; Kidney Calculi; Magnesium; Male; Middle Aged; Oxalates; Trichlormethiazide; Verapamil | 1993 |
Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzeneacetamides; Calcium Channel Blockers; Carcinoma, Ehrlich Tumor; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Glutathione Transferase; HeLa Cells; Humans; Hydroxamic Acids; Male; Mice; Oxalates; Verapamil | 1998 |
Deactivation of P-glycoprotein by a novel compound, oxalyl bis (N-phenyl) hydroxamic acid.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzeneacetamides; Blotting, Western; Cell Line; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; HeLa Cells; Humans; Hydroxamic Acids; Neoplasms; Oxalates; Verapamil | 2002 |
Modulation of doxorubicin sensitivity by a novel organic compound, oxalyl bis (N-phenyl) hydroxamic acid on acetyl aminofluorene-induced preneoplastic hepatocytes.
Topics: 2-Acetylaminofluorene; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzeneacetamides; Calcium Channel Blockers; Carcinogens; Cell Division; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Glutathione; Hepatocytes; Humans; Hydroxamic Acids; Male; Mice; Oxalates; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Spleen; Survival Rate; Tumor Cells, Cultured; Verapamil | 2003 |
Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria.
Topics: Allopurinol; Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Hyperoxaluria; In Situ Nick-End Labeling; Kidney Tubules; Male; Oxalates; Potassium Citrate; Rabbits; Random Allocation; Reference Values; Sensitivity and Specificity; Urinary Calculi; Urothelium; Verapamil; Vitamin E | 2004 |
Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzeneacetamides; Calcium Channel Blockers; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glycine; Humans; Hydroxamic Acids; Leukemia-Lymphoma, Adult T-Cell; Organometallic Compounds; Oxalates; Tumor Cells, Cultured; Verapamil | 2006 |
Effect of verapamil on urinary stone-forming risk factors.
Topics: Adult; Calcium Channel Blockers; Citrates; Female; Humans; Hyperoxaluria; Male; Middle Aged; Oxalates; Recurrence; Risk Factors; Time Factors; Urinary Calculi; Verapamil | 2007 |